Overview of Myocardial T1 Mapping Applications

被引：0
作者：
Varga-Szemes A. [1 ]
Muscogiuri G. [1 ,2 ]
Schoepf U.J. [1 ]
De Cecco C.N. [1 ]
Wichmann J.L. [1 ,3 ]
Mangold S. [1 ,4 ]
Caruso D. [1 ,2 ]
Fuller S.R. [1 ]
Spottiswoode B.S. [5 ]
van der Geest R.J. [6 ]
Suranyi P. [1 ]
机构：
[1] Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, 25 Courtenay Dr, MSC 226, Charleston, 29425, SC
[2] Department of Radiological, Oncological and Pathological Sciences, University of Rome “Sapienza”, Sede di Latina, 34 Via F. Faggiana, Rome
[3] Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Theodor-Stern-Kai 7, Frankfurt
[4] Department of Diagnostic and Interventional Radiology, Eberhard-Karls University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen
[5] Siemens Medical Solutions USA, Inc., 737 N Michigan Ave, Suite 1600, Chicago, 60611, IL
[6] Department of Radiology, Leiden University Medical Center, Albinusdreef 2, Leiden
来源：
Current Radiology Reports | / 3卷 / 9期
关键词：
Cardiovascular magnetic resonance; Contrast agent; Extracellular volume fraction; Myocardial tissue characterization; T1; mapping;
D O I：
10.1007/s40134-015-0114-z
中图分类号：
学科分类号：
摘要：
T1 mapping with cardiac MRI has gained an important role in myocardial tissue characterization over the past decade as emerging technological developments enable reliable myocardial T1 assessment with a reasonably short acquisition time. Fast mapping approaches can acquire a single-slice T1 map in a single breath-hold even in patients with low compliance and low breath-holding capacity. Improvements in T1 mapping sequences have extended the clinical utility of this technique to a broad range of myocardial diseases. Indeed, native T1 mapping and extracellular volume fraction mapping seem to have superior value over conventional late gadolinium enhancement techniques in assessing certain myocardial diseases. Ongoing studies look to establish inter-vendor reference values, to further shorten the acquisition time, to develop 3D T1 mapping, and to improve reliability and reproducibility. © 2015, Springer Science+Business Media New York.
引用
收藏
页数：13
相关论文
共 75 条
  • [1] Wang J., Qiu M., Constable R.T., In vivo method for correcting transmit/receive nonuniformities with phased array coils, Magn Reson Med, 53, 3, pp. 666-674, (2005)
  • [2] Suranyi P., Kiss P., Ruzsics B., Et al., Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement, Magn Reson Imaging, 25, 5, pp. 641-651, (2007)
  • [3] Sado D.M., Flett A.S., Moon J.C., Novel imaging techniques for diffuse myocardial fibrosis, Future Cardiol, 7, 5, pp. 643-650, (2011)
  • [4] Fontana M., Chung R., Hawkins P.N., Et al., Cardiovascular magnetic resonance for amyloidosis, Heart Fail Rev, 20, 2, pp. 133-144, (2015)
  • [5] Friedrich M.G., Sechtem U., Schulz-Menger J., Et al., Cardiovascular magnetic resonance in myocarditis: a JACC White Paper, J Am Coll Cardiol, 53, 17, pp. 1475-1487, (2009)
  • [6] Suranyi P., Kiss P., Brott B.C., Et al., Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution, Magn Reson Med, 56, 3, pp. 535-545, (2006)
  • [7] Damadian R., Tumor detection by nuclear magnetic resonance, Science, 171, 3976, pp. 1151-1153, (1971)
  • [8] Messroghli D.R., Radjenovic A., Kozerke S., Et al., Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart, Magn Reson Med, 52, 1, pp. 141-146, (2004)
  • [9] Flett A.S., Hayward M.P., Ashworth M.T., Et al., Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans, Circulation, 122, 2, pp. 138-144, (2010)
  • [10] Chow K., Flewitt J.A., Green J.D., Et al., Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping, Magn Reson Med, 71, 6, pp. 2082-2095, (2014)
12345678